News + Press

Texas Biomed Highlighted at Upcoming World Stem Cell Summit | 11.25.2014

San Antonio is host to the 2014 World Stem Cell Summit and RegMed Capital Conference. In advance of the conference, attendees are being offered the opportunity to tour three San Antonio resource facilities, including Texas Biomed. | Read the full story

Texas Biomed to Participate in Texas Public Radio's New "Think Science" Lecture Series | 11.17.2014

Dr. Anthony Griffiths is scheduled to address the community at a new series launched by Texas Public Radio called "Think Science" this Friday, November 21 at Tripoint YMCA. | Read the full story

SA Express News Reports on Texas Biomed Being at the Forefront of the Ebola Fight | 10.24.2014

Richard A. Marini with the San Antonio Express News reported in a story on October 14, 2014 how Texas Biomed is at the forefront of the Ebola fight. The institute has been working on an Ebola vaccine for the past 10 years. | Read the full story

KSAT 12 Streams Online the University of the Incarnate Panel Discussion on Ebola Which Includes Texas Biomed Scientist, Dr. Ricardo Carrion | 10.24.2014

Dr. Ricardo Carrion participated in an hour-long UIW panel discussion on Ebola this week which was streamed online by KSAT-12. | Read the full story

Mymetics’ Promising HIV Vaccine Candidate Obtains Funding to Begin Study at Texas Biomedical Research Institute | 09.30.2014

Epalinges, Switzerland, 29 September 2014 - Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial. The study will be led by Dr. Ruth Ruprecht, Scientist & Director of the Texas Biomed AIDS Research Program. | Read the full story

News 4 San Antonio Story Highlights Ebola Research at Texas Biomed | 09.22.2014

Lauren Lea with News 4 San Antonio reported in a story on September 19 how Texas Biomed has been working to detect, treat and discover a vaccine for the deadly Ebola virus. | Read the full story

Research Milestone in CCHF Virus Could Help Identify New Treatments | 09.18.2014

New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-borne virus which causes a severe hemorrhagic disease in humans similar to that caused by Ebolavirus, has identified new cellular factors essential for CCHFV infection. This discovery has the potential to lead to novel targets for therapeutic interventions against the pathogen. | Read the full story

Texas Biomed Gains $2.7 Million NIH Grant to Develop New Methods to Understand Genetic Basis of Diseases | 08.15.2014

The Texas Biomedical Research Institute has been awarded a $2.7 million grant from the U.S. National Institutes of Health to fund innovative approaches to genetics research aimed at developing new therapies for heart disease and other conditions with genetic components. | Read the full story

Robert Gracy Named Interim CEO at Texas Biomed | 07.22.2014

Robert W. Gracy, Ph.D., has been named Interim President and Chief Executive Officer of Texas Biomedical Research Institute, according to Board Chairman Richard Schlosberg. | Read the full story

Texas Biomed Regenerative Medicine Program Expands With Two New Research Scientists | 06.11.2014

Texas Biomedical Research Institute has recruited two new research scientists to its Southwest National Primate Research Center (SNPRC) who will focus on regenerative medicine, working with animal models to develop human stem cell therapies for medical conditions such as Parkinson’s disease, degenerative diseases of the eye and muscular dystrophy. Tiziano Barberi, PhD and Marcel M. Daadi, PhD join Texas Biomed as Associate Scientists in the SNPRC. | Read the full story